Cargando…

Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses

BACKGROUND: Herpes simplex virus type-1(HSV-1) and HSV-2 are important human pathogens that cause significant ocular and urogenital complications, respectively. We have previously shown that HSV-1 virions lacking glycoprotein K (gK) are unable to enter into neurons via synaptic axonal membranes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Arun V, Pahar, Bapi, Chouljenko, Vladimir N, Walker, Jason D, Stanfield, Brent, Kousoulas, Konstantin G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826548/
https://www.ncbi.nlm.nih.gov/pubmed/24165088
http://dx.doi.org/10.1186/1743-422X-10-317
_version_ 1782290923698257920
author Iyer, Arun V
Pahar, Bapi
Chouljenko, Vladimir N
Walker, Jason D
Stanfield, Brent
Kousoulas, Konstantin G
author_facet Iyer, Arun V
Pahar, Bapi
Chouljenko, Vladimir N
Walker, Jason D
Stanfield, Brent
Kousoulas, Konstantin G
author_sort Iyer, Arun V
collection PubMed
description BACKGROUND: Herpes simplex virus type-1(HSV-1) and HSV-2 are important human pathogens that cause significant ocular and urogenital complications, respectively. We have previously shown that HSV-1 virions lacking glycoprotein K (gK) are unable to enter into neurons via synaptic axonal membranes and be transported in either retrograde or anterograde manner. Here, we tested the ability of HSV-1 (F) gK-null to protect against lethal challenge with either highly virulent ocular HSV-1 (McKrae strain), or genital HSV-2 (G strain). The gK-null virus vaccine efficiently protected mice against lethal vaginal infection with either HSV-1(McKrae) or HSV-2 (G). RESULTS: Female mice were immunized via a single intramuscular injection with 10(6) PFU of the gK-null virus. Immunized mice were treated with Depo-Provera fourteen days after vaccination and were challenged via the vaginal route one week later. Ninety percent of mice vaccinated with the gK-null virus survived HSV-1 (McKrae) challenge, while 70% of these mice survived after HSV-2 (G) challenge. Moreover, all vaccinated mice exhibited substantially reduced disease symptoms irrespective of HSV-1 or HSV-2 challenge as compared to the mock vaccinated challenge group. T-cell memory immune responses to specific glycoprotein B (gB) and glycoprotein D (gD) peptide epitopes were detectable at 7 months post vaccination. CONCLUSIONS: These results suggest that the highly attenuated, non-neurotropic gK-null virus may be used as an effective vaccine to protect against both virulent HSV-1 and HSV-2 genital infections and induce lasting immune responses.
format Online
Article
Text
id pubmed-3826548
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38265482013-11-14 Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses Iyer, Arun V Pahar, Bapi Chouljenko, Vladimir N Walker, Jason D Stanfield, Brent Kousoulas, Konstantin G Virol J Research BACKGROUND: Herpes simplex virus type-1(HSV-1) and HSV-2 are important human pathogens that cause significant ocular and urogenital complications, respectively. We have previously shown that HSV-1 virions lacking glycoprotein K (gK) are unable to enter into neurons via synaptic axonal membranes and be transported in either retrograde or anterograde manner. Here, we tested the ability of HSV-1 (F) gK-null to protect against lethal challenge with either highly virulent ocular HSV-1 (McKrae strain), or genital HSV-2 (G strain). The gK-null virus vaccine efficiently protected mice against lethal vaginal infection with either HSV-1(McKrae) or HSV-2 (G). RESULTS: Female mice were immunized via a single intramuscular injection with 10(6) PFU of the gK-null virus. Immunized mice were treated with Depo-Provera fourteen days after vaccination and were challenged via the vaginal route one week later. Ninety percent of mice vaccinated with the gK-null virus survived HSV-1 (McKrae) challenge, while 70% of these mice survived after HSV-2 (G) challenge. Moreover, all vaccinated mice exhibited substantially reduced disease symptoms irrespective of HSV-1 or HSV-2 challenge as compared to the mock vaccinated challenge group. T-cell memory immune responses to specific glycoprotein B (gB) and glycoprotein D (gD) peptide epitopes were detectable at 7 months post vaccination. CONCLUSIONS: These results suggest that the highly attenuated, non-neurotropic gK-null virus may be used as an effective vaccine to protect against both virulent HSV-1 and HSV-2 genital infections and induce lasting immune responses. BioMed Central 2013-10-28 /pmc/articles/PMC3826548/ /pubmed/24165088 http://dx.doi.org/10.1186/1743-422X-10-317 Text en Copyright © 2013 Iyer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Iyer, Arun V
Pahar, Bapi
Chouljenko, Vladimir N
Walker, Jason D
Stanfield, Brent
Kousoulas, Konstantin G
Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses
title Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses
title_full Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses
title_fullStr Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses
title_full_unstemmed Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses
title_short Single dose of Glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses
title_sort single dose of glycoprotein k (gk)-deleted hsv-1 live-attenuated virus protects mice against lethal vaginal challenge with hsv-1 and hsv-2 and induces lasting t cell memory immune responses
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826548/
https://www.ncbi.nlm.nih.gov/pubmed/24165088
http://dx.doi.org/10.1186/1743-422X-10-317
work_keys_str_mv AT iyerarunv singledoseofglycoproteinkgkdeletedhsv1liveattenuatedvirusprotectsmiceagainstlethalvaginalchallengewithhsv1andhsv2andinduceslastingtcellmemoryimmuneresponses
AT paharbapi singledoseofglycoproteinkgkdeletedhsv1liveattenuatedvirusprotectsmiceagainstlethalvaginalchallengewithhsv1andhsv2andinduceslastingtcellmemoryimmuneresponses
AT chouljenkovladimirn singledoseofglycoproteinkgkdeletedhsv1liveattenuatedvirusprotectsmiceagainstlethalvaginalchallengewithhsv1andhsv2andinduceslastingtcellmemoryimmuneresponses
AT walkerjasond singledoseofglycoproteinkgkdeletedhsv1liveattenuatedvirusprotectsmiceagainstlethalvaginalchallengewithhsv1andhsv2andinduceslastingtcellmemoryimmuneresponses
AT stanfieldbrent singledoseofglycoproteinkgkdeletedhsv1liveattenuatedvirusprotectsmiceagainstlethalvaginalchallengewithhsv1andhsv2andinduceslastingtcellmemoryimmuneresponses
AT kousoulaskonstanting singledoseofglycoproteinkgkdeletedhsv1liveattenuatedvirusprotectsmiceagainstlethalvaginalchallengewithhsv1andhsv2andinduceslastingtcellmemoryimmuneresponses